Exploring HSP90α and hs-CRP using AI models to predict prognosis in advanced hepatocellular carcinoma treated with PD-1 inhibitors and targeted therapy
Zhen-Ying Wu(Panzhihua Central Hospital), Pan Wang(Tianjin Medical University Cancer Institute and Hospital), Wenting Du(Sun Yat-sen University), Qian Wei(Southwest Medical University), Lianbin Wen(Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital), Xian‐Guo Liu(Sun Yat-sen University), Hongyan Li(Jinan University), Lu Yang(Wuhan University), Junqi Liu(University of Minnesota), Xueting Li(Harbin Medical University), Yanqiong Song(University of Electronic Science and Technology of China), Yue Tu(Logistics University of People's Armed Police Force)
Cited by 0
Related Papers
DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application
|Clinical Epigenetics|2021|253
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
|Nature Medicine|2024|116
Sitravatinib potentiates immune checkpoint blockade in refractory cancer models
|JCI Insight|2018|111
The Upregulation of Translocator Protein (18 kDa) Promotes Recovery from Neuropathic Pain in Rats
|Journal of Neuroscience|2013|91
Loss of RPS27a expression regulates the cell cycle, apoptosis, and proliferation via the RPL11-MDM2-p53 pathway in lung adenocarcinoma cells
|Journal of Experimental & Clinical Cancer Research|2022|87